Literature DB >> 18787462

Long-term follow-up study of gastric intraepithelial neoplasias: progression from low-grade dysplasia to invasive carcinoma.

Soo Young Park1, Seong Woo Jeon, Min Kyu Jung, Chang Min Cho, Won Young Tak, Young Oh Kweon, Sung Kook Kim, Yong Hwan Choi.   

Abstract

BACKGROUND AND STUDY AIMS: A gastric intraepithelial neoplasia (IEN) is usually regarded as a precancerous lesion; however, the natural history of the gastric IEN has not been clarified. We aimed to evaluate the progression of dysplasia in gastric IENs. PATIENTS AND METHODS: As a retrospective study, we reviewed 26 gastric adenomas with low-grade dysplasia (LGD) and one with high-grade dysplasia (HGD) from 18 patients. The patients were followed up for a median of 66 months from 1996 to 2004 (mean 58 months, 20-112 months) in Kyungpook National University Hospital. The histological diagnosis was classified according to the Vienna classification. We reviewed clinical (age and sex), morphological (size, color, shape, location in stomach, surface nodularity, and presence of the erosion), and histological (histological diagnosis, infection with Helicobacter pylori, infiltration of inflammatory cells, atrophy, intestinal metaplasia, microscopic erosions, and glandular appearance) characteristics with regard to progression of dysplasia.
RESULTS: We found eight IENs of progressive dysplasia (29.6%). One IEN with HGD and three IENs with LGD progressed to invasive adenocarcinoma (category 5). Four gastric IENs with LGD progressed to HGD (category 4). The clinical, morphological, and histological characteristics did not reveal any distinguishable features for progressive dysplasia.
CONCLUSION: For the potential risk of progressive dysplasia, gastric IENs should be treated actively using the recently advanced therapeutic endoscopic techniques, regardless of the degrees of dysplasia.

Entities:  

Mesh:

Year:  2008        PMID: 18787462     DOI: 10.1097/MEG.0b013e3283013d58

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  35 in total

1.  Gastric adenoma with low-grade dysplasia: two countries, two outcomes.

Authors:  Sun-Young Lee
Journal:  Dig Dis Sci       Date:  2013-09-20       Impact factor: 3.199

Review 2.  Optimal management of biopsy-proven low-grade gastric dysplasia.

Authors:  Jung-Wook Kim; Jae Young Jang
Journal:  World J Gastrointest Endosc       Date:  2015-04-16

3.  Endoscopic and histopathological characteristics suggesting the presence of gastric mucosal high grade neoplasia foci in cases initially diagnosed as gastric mucosal low grade neoplasia by forceps biopsy in Korea.

Authors:  Byung-Hoon Min; Kyoung-Mee Kim; Eun Ran Kim; Cheol Keun Park; Jae J Kim; Hyuk Lee; Jun Haeng Lee; Dong Kyung Chang; Young-Ho Kim; Poong-Lyul Rhee; Jong Chul Rhee
Journal:  J Gastroenterol       Date:  2010-07-31       Impact factor: 7.527

4.  Epithelial dysplasia of the stomach with gastric immunophenotype shows features of biological aggressiveness.

Authors:  Pedro Valente; Mónica Garrido; Irene Gullo; Helena Baldaia; Margarida Marques; Francisco Baldaque-Silva; Joanne Lopes; Fátima Carneiro
Journal:  Gastric Cancer       Date:  2014-08-22       Impact factor: 7.370

5.  A randomized trial to determine the diagnostic accuracy of conventional vs. jumbo forceps biopsy of gastric epithelial neoplasias before endoscopic submucosal dissection; open-label study.

Authors:  Hyo Keun Jeon; Ho Yoel Ryu; Mee Yon Cho; Hyun-Soo Kim; Jae Woo Kim; Hong Jun Park; Moon Young Kim; Soon Koo Baik; Sang Ok Kwon; Su Yeon Park; Sung Ho Won
Journal:  Gastric Cancer       Date:  2013-12-13       Impact factor: 7.370

6.  Screening endoscopy for gastric cancer: time for quality control.

Authors:  Eun Hye Kim; Chan Hyuk Park
Journal:  Transl Gastroenterol Hepatol       Date:  2017-09-27

7.  Treatment strategy for gastric non-invasive intraepithelial neoplasia diagnosed by endoscopic biopsy.

Authors:  Tsutomu Nishida; Shusaku Tsutsui; Motohiko Kato; Takuya Inoue; Shunsuke Yamamoto; Yoshito Hayashi; Tomofumi Akasaka; Takuya Yamada; Shinichiro Shinzaki; Hideki Iijima; Masahiko Tsujii; Tetsuo Takehara
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

8.  Comparative study of Western and Japanese criteria for biopsy-based diagnosis of gastric epithelial neoplasia.

Authors:  Masao Yoshida; Tadakazu Shimoda; Kimihide Kusafuka; Takashi Sugino; Takashi Nakajima; Hiroyuki Ono
Journal:  Gastric Cancer       Date:  2014-05-01       Impact factor: 7.370

9.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

10.  The risk factors for discrepancy after endoscopic submucosal dissection of gastric category 3 lesion (low grade dysplasia).

Authors:  Cheol Woong Choi; Hyung Wook Kim; Dong Hoon Shin; Dae Hwan Kang; Yong Mi Hong; Jin Hyun Park; Su Bum Park; Mong Cho; Jung Hee Lee
Journal:  Dig Dis Sci       Date:  2013-12-24       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.